收藏切换
Evaluation of SGLT-2 inhibitors for type 2 diabetes mellitus treatment effectiveness
收藏切换
PDF
Xin-yi MA, Pan-pan XIE, Zhi-xing CHEN, Xi WENG, Ai-xin SHI
Chinese Journal of Clinical Pharmacology | 2025, 41(8) : 1164 - 1169
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(8): 1164-1169
Research Method
Evaluation of SGLT-2 inhibitors for type 2 diabetes mellitus treatment effectiveness
Full
Xin-yi MA, Pan-pan XIE, Zhi-xing CHEN, Xi WENG, Ai-xin SHI
Affiliations
  • Clinical Trial Research Center, Beijing Hospital, National Geriatric Center, Chinese Academy of Medical Sciences Institute of Geriatrics, Beijing 100730, China
Published: 2025-04-28 doi: 10.13699/j.cnki.1001-6821.2025.08.020
Outline
收藏切换
Objective

To establish a pharmacodynamic model of sodium-glucose transporter 2 inhibitors (SGLT-2i) in order to evaluate the efficacy characteristics of the drugs.

Methods

A model-based meta-analysis was used. By searching randomized controlled trials of SGLT-2i monotherapy in patients with type 2 diabetes (T2DM) in databases, the change in glycosylated hemoglobin (HbA1c) from baseline was used as the efficacy indicator. The pharmacodynamic models of SGLT-2i and placebo were constructed, and the covariates were screened to determine the factors affecting the drug’s efficacy.

Results

A total of 39 studies were included, involving 96 trial groups, 8 534 participants, and 13 drugs (dapagliflozin, canagliflozin, empagliflozin, ipragliflozin, luseogliflozin, ertuglilfozin, enavogliflozin, henagliflozin, licogliflozin, sotagliflozin, bexagliflozin, janagliflozin and tofogliflozin). The time-effect relationships of the drug group and the placebo group were consistent with the Emax model, and fasting plasma glucose baseline had an effect on the pharmacodynamic parameters of SGLT-2i.

Conclusion

The final model can describe the pharmacodynamic characteristics of the drug and placebo groups, and there is a significant association between FPB baseline and drug efficacy.

sodium-glucose transporter-2 inhibitor  /  model-based meta-analysis  /  type 2 diabetes  /  hemoglobin A1c  /  pharmacodynamic model
Xin-yi MA, Pan-pan XIE, Zhi-xing CHEN, Xi WENG, Ai-xin SHI. Evaluation of SGLT-2 inhibitors for type 2 diabetes mellitus treatment effectiveness[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (8) : 1164 -1169 . DOI: 10.13699/j.cnki.1001-6821.2025.08.020
Year 2025 volume 41 Issue 8
PDF
2
1
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.08.020
  • Receive Date:2024-11-14
  • Online Date:2026-08-04
  • Published:2025-04-28
Article Data
Affiliations
History
  • Received:2024-11-14
Funding
Affiliations
    Clinical Trial Research Center, Beijing Hospital, National Geriatric Center, Chinese Academy of Medical Sciences Institute of Geriatrics, Beijing 100730, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.08.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT